0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Detection Services Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-38D18036
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Tumor Detection Services Market Research Report 2024
BUY CHAPTERS

Global Tumor Detection Services Market Research Report 2026

Code: QYRE-Auto-38D18036
Report
2026-02-10
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Detection Services Market

The global Tumor Detection Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Tumor detection services are medical services that aim to detect and diagnose cancer at an early stage through a series of medical examinations and tests. These services typically include imaging examinations (such as CT, MRI, ultrasound), laboratory tests (such as blood tests, tumor marker tests), and tissue biopsies. By analyzing the patient's symptoms, medical history, and test results, doctors can assess the presence and type of cancer and develop personalized treatment plans. Early detection can significantly improve cure and survival rates and promote overall health management for patients.
The North American market for Tumor Detection Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Tumor Detection Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Tumor Detection Services in Adults is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Tumor Detection Services include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Tumor Detection Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tumor Detection Services. The Tumor Detection Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tumor Detection Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tumor Detection Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Tumor Detection Services Market Report

Report Metric Details
Report Name Tumor Detection Services Market
Segment by Type
  • Non-Invasive Examination
  • Invasive Examination
Segment by Application
  • Adults
  • Children
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, Dxcover, Caris Life Sciences, Novocure, Circulogene, Guardant Health, Veracyte, Haystack Oncology, Foundation Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Tumor Detection Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Detection Services Market report?

Ans: The main players in the Tumor Detection Services Market are Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, Dxcover, Caris Life Sciences, Novocure, Circulogene, Guardant Health, Veracyte, Haystack Oncology, Foundation Medicine

What are the Application segmentation covered in the Tumor Detection Services Market report?

Ans: The Applications covered in the Tumor Detection Services Market report are Adults, Children

What are the Type segmentation covered in the Tumor Detection Services Market report?

Ans: The Types covered in the Tumor Detection Services Market report are Non-Invasive Examination, Invasive Examination

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Detection Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Non-Invasive Examination
1.2.3 Invasive Examination
1.3 Market by Application
1.3.1 Global Tumor Detection Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Detection Services Market Perspective (2021–2032)
2.2 Global Tumor Detection Services Growth Trends by Region
2.2.1 Global Tumor Detection Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Tumor Detection Services Historic Market Size by Region (2021–2026)
2.2.3 Tumor Detection Services Forecasted Market Size by Region (2027–2032)
2.3 Tumor Detection Services Market Dynamics
2.3.1 Tumor Detection Services Industry Trends
2.3.2 Tumor Detection Services Market Drivers
2.3.3 Tumor Detection Services Market Challenges
2.3.4 Tumor Detection Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Detection Services Players by Revenue
3.1.1 Global Top Tumor Detection Services Players by Revenue (2021–2026)
3.1.2 Global Tumor Detection Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Tumor Detection Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Tumor Detection Services Revenue
3.4 Global Tumor Detection Services Market Concentration Ratio
3.4.1 Global Tumor Detection Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Detection Services Revenue in 2025
3.5 Global Key Players of Tumor Detection Services Head Offices and Areas Served
3.6 Global Key Players of Tumor Detection Services, Products and Applications
3.7 Global Key Players of Tumor Detection Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Tumor Detection Services Breakdown Data by Type
4.1 Global Tumor Detection Services Historic Market Size by Type (2021–2026)
4.2 Global Tumor Detection Services Forecasted Market Size by Type (2027–2032)
5 Tumor Detection Services Breakdown Data by Application
5.1 Global Tumor Detection Services Historic Market Size by Application (2021–2026)
5.2 Global Tumor Detection Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Tumor Detection Services Market Size (2021–2032)
6.2 North America Tumor Detection Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Tumor Detection Services Market Size by Country (2021–2026)
6.4 North America Tumor Detection Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Detection Services Market Size (2021–2032)
7.2 Europe Tumor Detection Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Tumor Detection Services Market Size by Country (2021–2026)
7.4 Europe Tumor Detection Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Tumor Detection Services Market Size (2021–2032)
8.2 Asia-Pacific Tumor Detection Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Tumor Detection Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Tumor Detection Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Tumor Detection Services Market Size (2021–2032)
9.2 Latin America Tumor Detection Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Tumor Detection Services Market Size by Country (2021–2026)
9.4 Latin America Tumor Detection Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Detection Services Market Size (2021–2032)
10.2 Middle East & Africa Tumor Detection Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Tumor Detection Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Tumor Detection Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nonacus
11.1.1 Nonacus Company Details
11.1.2 Nonacus Business Overview
11.1.3 Nonacus Tumor Detection Services Introduction
11.1.4 Nonacus Revenue in Tumor Detection Services Business (2021–2026)
11.1.5 Nonacus Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Tumor Detection Services Introduction
11.2.4 Natera Revenue in Tumor Detection Services Business (2021–2026)
11.2.5 Natera Recent Development
11.3 Penn Medicine
11.3.1 Penn Medicine Company Details
11.3.2 Penn Medicine Business Overview
11.3.3 Penn Medicine Tumor Detection Services Introduction
11.3.4 Penn Medicine Revenue in Tumor Detection Services Business (2021–2026)
11.3.5 Penn Medicine Recent Development
11.4 Amadix
11.4.1 Amadix Company Details
11.4.2 Amadix Business Overview
11.4.3 Amadix Tumor Detection Services Introduction
11.4.4 Amadix Revenue in Tumor Detection Services Business (2021–2026)
11.4.5 Amadix Recent Development
11.5 Oncologica
11.5.1 Oncologica Company Details
11.5.2 Oncologica Business Overview
11.5.3 Oncologica Tumor Detection Services Introduction
11.5.4 Oncologica Revenue in Tumor Detection Services Business (2021–2026)
11.5.5 Oncologica Recent Development
11.6 Rarecells
11.6.1 Rarecells Company Details
11.6.2 Rarecells Business Overview
11.6.3 Rarecells Tumor Detection Services Introduction
11.6.4 Rarecells Revenue in Tumor Detection Services Business (2021–2026)
11.6.5 Rarecells Recent Development
11.7 GRAIL
11.7.1 GRAIL Company Details
11.7.2 GRAIL Business Overview
11.7.3 GRAIL Tumor Detection Services Introduction
11.7.4 GRAIL Revenue in Tumor Detection Services Business (2021–2026)
11.7.5 GRAIL Recent Development
11.8 Elypta
11.8.1 Elypta Company Details
11.8.2 Elypta Business Overview
11.8.3 Elypta Tumor Detection Services Introduction
11.8.4 Elypta Revenue in Tumor Detection Services Business (2021–2026)
11.8.5 Elypta Recent Development
11.9 Bio-Techne
11.9.1 Bio-Techne Company Details
11.9.2 Bio-Techne Business Overview
11.9.3 Bio-Techne Tumor Detection Services Introduction
11.9.4 Bio-Techne Revenue in Tumor Detection Services Business (2021–2026)
11.9.5 Bio-Techne Recent Development
11.10 iCAD
11.10.1 iCAD Company Details
11.10.2 iCAD Business Overview
11.10.3 iCAD Tumor Detection Services Introduction
11.10.4 iCAD Revenue in Tumor Detection Services Business (2021–2026)
11.10.5 iCAD Recent Development
11.11 Dxcover
11.11.1 Dxcover Company Details
11.11.2 Dxcover Business Overview
11.11.3 Dxcover Tumor Detection Services Introduction
11.11.4 Dxcover Revenue in Tumor Detection Services Business (2021–2026)
11.11.5 Dxcover Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Tumor Detection Services Introduction
11.12.4 Caris Life Sciences Revenue in Tumor Detection Services Business (2021–2026)
11.12.5 Caris Life Sciences Recent Development
11.13 Novocure
11.13.1 Novocure Company Details
11.13.2 Novocure Business Overview
11.13.3 Novocure Tumor Detection Services Introduction
11.13.4 Novocure Revenue in Tumor Detection Services Business (2021–2026)
11.13.5 Novocure Recent Development
11.14 Circulogene
11.14.1 Circulogene Company Details
11.14.2 Circulogene Business Overview
11.14.3 Circulogene Tumor Detection Services Introduction
11.14.4 Circulogene Revenue in Tumor Detection Services Business (2021–2026)
11.14.5 Circulogene Recent Development
11.15 Guardant Health
11.15.1 Guardant Health Company Details
11.15.2 Guardant Health Business Overview
11.15.3 Guardant Health Tumor Detection Services Introduction
11.15.4 Guardant Health Revenue in Tumor Detection Services Business (2021–2026)
11.15.5 Guardant Health Recent Development
11.16 Veracyte
11.16.1 Veracyte Company Details
11.16.2 Veracyte Business Overview
11.16.3 Veracyte Tumor Detection Services Introduction
11.16.4 Veracyte Revenue in Tumor Detection Services Business (2021–2026)
11.16.5 Veracyte Recent Development
11.17 Haystack Oncology
11.17.1 Haystack Oncology Company Details
11.17.2 Haystack Oncology Business Overview
11.17.3 Haystack Oncology Tumor Detection Services Introduction
11.17.4 Haystack Oncology Revenue in Tumor Detection Services Business (2021–2026)
11.17.5 Haystack Oncology Recent Development
11.18 Foundation Medicine
11.18.1 Foundation Medicine Company Details
11.18.2 Foundation Medicine Business Overview
11.18.3 Foundation Medicine Tumor Detection Services Introduction
11.18.4 Foundation Medicine Revenue in Tumor Detection Services Business (2021–2026)
11.18.5 Foundation Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Tumor Detection Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Non-Invasive Examination
 Table 3. Key Players of Invasive Examination
 Table 4. Global Tumor Detection Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Tumor Detection Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Tumor Detection Services Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Tumor Detection Services Market Share by Region (2021–2026)
 Table 8. Global Tumor Detection Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Tumor Detection Services Market Share by Region (2027–2032)
 Table 10. Tumor Detection Services Market Trends
 Table 11. Tumor Detection Services Market Drivers
 Table 12. Tumor Detection Services Market Challenges
 Table 13. Tumor Detection Services Market Restraints
 Table 14. Global Tumor Detection Services Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Tumor Detection Services Market Share by Players (2021–2026)
 Table 16. Global Top Tumor Detection Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tumor Detection Services Revenue, 2025
 Table 17. Ranking of Global Top Tumor Detection Services Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Tumor Detection Services Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Tumor Detection Services, Headquarters and Area Served
 Table 20. Global Key Players of Tumor Detection Services, Products and Applications
 Table 21. Global Key Players of Tumor Detection Services, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Tumor Detection Services Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Tumor Detection Services Revenue Market Share by Type (2021–2026)
 Table 25. Global Tumor Detection Services Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Tumor Detection Services Revenue Market Share by Type (2027–2032)
 Table 27. Global Tumor Detection Services Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Tumor Detection Services Revenue Market Share by Application (2021–2026)
 Table 29. Global Tumor Detection Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Tumor Detection Services Revenue Market Share by Application (2027–2032)
 Table 31. North America Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Tumor Detection Services Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Tumor Detection Services Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Tumor Detection Services Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Tumor Detection Services Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Tumor Detection Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Tumor Detection Services Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Tumor Detection Services Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Tumor Detection Services Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Tumor Detection Services Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Tumor Detection Services Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Tumor Detection Services Market Size by Country (US$ Million), 2027–2032
 Table 46. Nonacus Company Details
 Table 47. Nonacus Business Overview
 Table 48. Nonacus Tumor Detection Services Product
 Table 49. Nonacus Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 50. Nonacus Recent Development
 Table 51. Natera Company Details
 Table 52. Natera Business Overview
 Table 53. Natera Tumor Detection Services Product
 Table 54. Natera Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 55. Natera Recent Development
 Table 56. Penn Medicine Company Details
 Table 57. Penn Medicine Business Overview
 Table 58. Penn Medicine Tumor Detection Services Product
 Table 59. Penn Medicine Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 60. Penn Medicine Recent Development
 Table 61. Amadix Company Details
 Table 62. Amadix Business Overview
 Table 63. Amadix Tumor Detection Services Product
 Table 64. Amadix Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 65. Amadix Recent Development
 Table 66. Oncologica Company Details
 Table 67. Oncologica Business Overview
 Table 68. Oncologica Tumor Detection Services Product
 Table 69. Oncologica Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 70. Oncologica Recent Development
 Table 71. Rarecells Company Details
 Table 72. Rarecells Business Overview
 Table 73. Rarecells Tumor Detection Services Product
 Table 74. Rarecells Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 75. Rarecells Recent Development
 Table 76. GRAIL Company Details
 Table 77. GRAIL Business Overview
 Table 78. GRAIL Tumor Detection Services Product
 Table 79. GRAIL Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 80. GRAIL Recent Development
 Table 81. Elypta Company Details
 Table 82. Elypta Business Overview
 Table 83. Elypta Tumor Detection Services Product
 Table 84. Elypta Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 85. Elypta Recent Development
 Table 86. Bio-Techne Company Details
 Table 87. Bio-Techne Business Overview
 Table 88. Bio-Techne Tumor Detection Services Product
 Table 89. Bio-Techne Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 90. Bio-Techne Recent Development
 Table 91. iCAD Company Details
 Table 92. iCAD Business Overview
 Table 93. iCAD Tumor Detection Services Product
 Table 94. iCAD Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 95. iCAD Recent Development
 Table 96. Dxcover Company Details
 Table 97. Dxcover Business Overview
 Table 98. Dxcover Tumor Detection Services Product
 Table 99. Dxcover Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 100. Dxcover Recent Development
 Table 101. Caris Life Sciences Company Details
 Table 102. Caris Life Sciences Business Overview
 Table 103. Caris Life Sciences Tumor Detection Services Product
 Table 104. Caris Life Sciences Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 105. Caris Life Sciences Recent Development
 Table 106. Novocure Company Details
 Table 107. Novocure Business Overview
 Table 108. Novocure Tumor Detection Services Product
 Table 109. Novocure Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 110. Novocure Recent Development
 Table 111. Circulogene Company Details
 Table 112. Circulogene Business Overview
 Table 113. Circulogene Tumor Detection Services Product
 Table 114. Circulogene Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 115. Circulogene Recent Development
 Table 116. Guardant Health Company Details
 Table 117. Guardant Health Business Overview
 Table 118. Guardant Health Tumor Detection Services Product
 Table 119. Guardant Health Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 120. Guardant Health Recent Development
 Table 121. Veracyte Company Details
 Table 122. Veracyte Business Overview
 Table 123. Veracyte Tumor Detection Services Product
 Table 124. Veracyte Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 125. Veracyte Recent Development
 Table 126. Haystack Oncology Company Details
 Table 127. Haystack Oncology Business Overview
 Table 128. Haystack Oncology Tumor Detection Services Product
 Table 129. Haystack Oncology Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 130. Haystack Oncology Recent Development
 Table 131. Foundation Medicine Company Details
 Table 132. Foundation Medicine Business Overview
 Table 133. Foundation Medicine Tumor Detection Services Product
 Table 134. Foundation Medicine Revenue in Tumor Detection Services Business (US$ Million), 2021–2026
 Table 135. Foundation Medicine Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Tumor Detection Services Picture
 Figure 2. Global Tumor Detection Services Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Tumor Detection Services Market Share by Type: 2025 vs 2032
 Figure 4. Non-Invasive Examination Features
 Figure 5. Invasive Examination Features
 Figure 6. Global Tumor Detection Services Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Tumor Detection Services Market Share by Application: 2025 vs 2032
 Figure 8. Adults Case Studies
 Figure 9. Children Case Studies
 Figure 10. Tumor Detection Services Report Years Considered
 Figure 11. Global Tumor Detection Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Tumor Detection Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Tumor Detection Services Market Share by Region: 2025 vs 2032
 Figure 14. Global Tumor Detection Services Market Share by Players in 2025
 Figure 15. Global Tumor Detection Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Tumor Detection Services Revenue in 2025
 Figure 17. North America Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Tumor Detection Services Market Share by Country (2021–2032)
 Figure 19. United States Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Tumor Detection Services Market Share by Country (2021–2032)
 Figure 23. Germany Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Tumor Detection Services Market Share by Region (2021–2032)
 Figure 31. China Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Tumor Detection Services Market Share by Country (2021–2032)
 Figure 39. Mexico Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Tumor Detection Services Market Share by Country (2021–2032)
 Figure 43. Israel Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Tumor Detection Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Nonacus Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 47. Natera Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 48. Penn Medicine Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 49. Amadix Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 50. Oncologica Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 51. Rarecells Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 52. GRAIL Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 53. Elypta Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 54. Bio-Techne Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 55. iCAD Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 56. Dxcover Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 57. Caris Life Sciences Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 58. Novocure Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 59. Circulogene Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 60. Guardant Health Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 61. Veracyte Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 62. Haystack Oncology Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 63. Foundation Medicine Revenue Growth Rate in Tumor Detection Services Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS